Futian Zhang

Futian Zhang

Auto-generated profile, based on publicly available information

Futian Zhang

University of Waterloo, Waterloo, Canada

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2022 in Proceedings of the ACM on Human-Computer Interaction
Verified
Journal Article
Open access
FZFutian Zhang
Futian Zhang
KKKeiko Katsuragawa
Keiko Katsuragawa
ELEdward Lank
Edward Lank
Pointing is an elementary interaction in virtual and augmented reality environments, and, to effectively support selection, techniques must deal with the challenges of occlusion and depth specification. Most of the previous techniques require two explicit steps to handle occlusion. In this paper, we propose Conductor, an intuitive, plane-ray, intersection-based, 3D pointing technique where users leverage bimanual input to control a ray and intersecting plane. Conductor allows users to use the non-dominant hand to adjust the cursor distance on the ray while pointing with the dominant hand. We evaluate Conductor against Raycursor, a state-of-the-art VR pointing technique, and show that Conductor outperforms Raycursor for selection tasks. Given our results, we argue that bimanual selection techniques merit additional exploration to support object selection and placement within virtual environments.

17 January 2020 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
ZCZhaohui Chen
Zhaohui Chen
LYLi-Kun Yang
Li-Kun Yang
LCLiang Chen
Liang Chen
LJLi Jin
Li Jin
FZFutian Zhang
Futian Zhang
JZJun Zhao
Jun Zhao
Bladder cancer is one of the most common urogenital malignancies. However, its pathogenesis, especially molecular mechanisms remain elusive. Thus, understanding the molecular mechanisms underlying bladder cancer is important for the discovery of novel therapeutic paradigms for these diseases. In current study, we found that micro‐RNA (miR)‐190b is highly expressed in bladder cancer tissues and cells. Overexpression of miR‐190b enhanced the proliferation, growth, migration and invasion capabilities, and angiogenesis of bladder cancer cells, whereas downregulation of miR‐190b reversed these effects. Target prediction and dual luciferase reporter assays identified NLR family CARD domain containing 3 (NLRC3) as a potential target of miR‐190b. Pathway analysis indicated that miR‐190b promotes bladder cancer progression via the Wnt/β‐catenin and mTOR signaling pathways. Taken together, our findings imply that miR‐190b acts as a critical regulator for bladder cancer development by repressing NLRC3 and partly through the Wnt/β‐catenin and mTOR pathways. Our study suggests that miR‐190b may be served as a potential therapeutic target for bladder cancer treatment.